This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LIPOSARCOMA_EXALLC for full statistics.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C48.2|C49.2
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
885[0-4]|8858
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
176
Check minimum number of events None
176
Include endpoints None
176
Remove individuals based on genotype QC
170
C3_LIPOSARCOMA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Liposarcoma
based on the number of shared cases.
Broader endpoints:
- Liposarcoma (controls excluding all cancers)
- Any event in cancer register
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 170 | 61 | 109 |
| Unadjusted prevalence (%) | 0.04 | 0.03 | 0.06 |
| Mean age at first event (years) | 58.77 | 56.31 | 60.14 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_LIPOSARCOMA – Liposarcoma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Liposarcoma
↥Endpoint not on priority list, no data to show.